CG
BPMC

Cutler Group’s Blueprint Medicines BPMC Stock Holding History

Cutler Group’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,000
Closed -$50K – 3641
2023
Q3 		$50K Buy
1,000
+944
+1,686% +$50.4K 0.01% 1506
2023
Q2 		$3K Sell
56
-1,744
-97% -$94.8K ﹤0.01% 2813
2023
Q1 		$80K Hold
1,800
– – 0.01% 1089
2022
Q4 		$78K Hold
1,800
– – 0.01% 1312
2022
Q3 		$118K Sell
1,800
-3,200
-64% -$206K 0.01% 1267
2022
Q2 		$252K Buy
5,000
+3,660
+273% +$214K 0.02% 874
2022
Q1 		$85K Sell
1,340
-660
-33% -$47.4K ﹤0.01% 1813
2021
Q4 		$214K Sell
2,000
-1,000
-33% -$105K 0.01% 1264
2021
Q3 		$308K Sell
3,000
-640
-18% -$59.6K 0.01% 1076
2021
Q2 		$320K Hold
3,640
– – 0.01% 1014
2021
Q1 		$353K Buy
+3,640
New +$363K 0.02% 919
2020
Q3 		– Sell
-900
Closed -$69.3K – 4686
2020
Q2 		$70K Sell
900
-1,000
-53% -$67.6K ﹤0.01% 1516
2020
Q1 		$111K Buy
1,900
+700
+58% +$45K 0.01% 1280
2019
Q4 		$96K Sell
1,200
-4,000
-77% -$299K 0.01% 1224
2019
Q3 		$382K Buy
5,200
+3,280
+171% +$284K 0.03% 434
2019
Q2 		$181K Sell
1,920
-1,480
-44% -$122K 0.02% 770
2019
Q1 		$272K Buy
3,400
+900
+36% +$66.5K 0.03% 528
2018
Q4 		$134K Buy
2,500
+1,100
+79% +$66.9K 0.01% 863
2018
Q3 		$109K Sell
1,400
-400
-22% -$27.8K 0.01% 1148
2018
Q2 		$114K Buy
+1,800
New +$143K 0.01% 1065
2017
Q2 		– Sell
-11,424
Closed -$485K – 6366
2017
Q1 		$456K Buy
+11,424
New +$409K 0.02% 684

Other funds holding BPMC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Cutler Group's BPMC Position: Q4 2023 in Review

Cutler Group sold out of Blueprint Medicines (BPMC) in Q4 2023, closing a stake of 1,000 shares — an estimated $50K sold.

Cutler Group first reported a position in BPMC in Q1 2017 and held it in 21 quarters. The position peaked at $456K in Q1 2017. 259 funds tracked by Wall St. Rank hold BPMC as of Q4 2023.

  • Cutler Group reported no remaining Blueprint Medicines position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 1,000 Blueprint Medicines shares in Q4 2023, an estimated $50K.
  • Cutler Group first reported a position in Blueprint Medicines in Q1 2017 and held it in 21 quarters.
  • Cutler Group's Blueprint Medicines position peaked at $456K in Q1 2017.
  • 259 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.